Call for papers: Cell and molecular therapy for cardiovascular disorders
BMC Cardiovascular Disorders is calling for submissions to our Collection on cell and molecular therapy for cardiovascular diseases. Scientists from around the globe are investigating/leveraging cell and molecular-based strategies to protect, regenerate, replace, and restore the function of cardiac and vascular tissue. Advances in basic and clinical research have yielded encouraging findings highlighting the promise of such strategies to treat a range of CVDs. However, gaps in our knowledge remain and further research is required to translate findings from basic research into the clinic.
In support of SDG 3: Good Health & Wellbeing, BMC Cardiovascular Disorders calls for papers exploring the potential of stem cells, gene editing, tissue engineering, disease modeling, and organoids to improve our understanding of cardiovascular diseases and open new avenues for therapeutic intervention.
Meet the Guest Editors
Sherin Saheera: University of Massachusetts Chan Medical School, USDr Sherin Saheera completed her PhD in India in 2017 and went to the US to pursue her postdoctoral studies. After a year of training at the University of Alabama at Birmingham, she is currently working as a Postdoctoral Associate at the University of Massachusetts, Chan Medical School, where she has been since January 2019. She has over 18 publications in peer reviewed high impact journals and has been serving as an editorial board member and reviewer for reputed journals. She has also presented papers in several national and international conferences.
Huiliang Zhang: University of Arkansas for Medical Sciences, US
Dr Zhang’s research focuses on cardiac dysfunction in the aging heart with an emphasis on the pathogenic role of elevated proton leak from mitochondria. He explores the strategies for restoring mitochondrial function and stem cell therapies to reverse cardiac dysfunction in preclinical models of aging. Dr. Zhang is the principal investigator of the NIH R35 grant and the American Heart Association (AHA) Career Development Award. Dr. Zhang served in NIH and AHA study sections. He has nearly 40 original publications and has won several national trainee and junior faculty awards.
Submission Guidelines
This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Cell and molecular therapy for cardiovascular disorders" from the dropdown menu.Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
Submission Status: Open | Submission Deadline: 21 June 2024
Follow the Topic
-
BMC Cardiovascular Disorders
This journal is an open access, peer-reviewed journal that considers articles on the characterization, prevention, diagnosis and treatment of disorders of the heart and circulatory system.
Related Collections
With collections, you can get published faster and increase your visibility.
Omics approaches to understand cardiovascular disease
BMC Cardiovascular Disorders is calling for submissions to our Collection on Omics approaches to understand cardiovascular disease. Omics approaches have emerged as indispensable tools in unraveling the intricate molecular landscape of cardiovascular disease (CVD) by providing comprehensive insights into the underlying mechanisms driving CVD pathogenesis, progression, and response to therapy. Integrative omics approaches further enhance our understanding by integrating multi-omics data to explain complex molecular networks and identify novel disease pathways.
The application of omics technologies holds immense promise in advancing precision medicine approaches for CVD management. By leveraging omics data, clinicians can stratify patients based on their molecular profiles, enabling tailored treatment strategies and improving therapeutic outcomes. Omics-based biomarkers offer non-invasive tools for early disease detection, risk prediction, and monitoring disease progression. Omics approaches represent a transformative paradigm in cardiovascular research, and clinical practice, offering unprecedented opportunities to decipher the molecular intricacies of CVD and revolutionize patient care.
In support of SDG 3: Good Health & Well-being, this Collection seeks contributions that address a spectrum of topics, including but not limited to:
• Genomics
• Transcriptomics
• Proteomics
• Metabolomics
• Epigenomics
• Integrative omics analyses
• Omics-based biomarker discovery
• Molecular pathways in cardiovascular disease
• Personalized medicine approaches
• Therapeutic targets and drug development
• Clinical applications of omics technologies in cardiovascular medicine
Publishing Model: Open Access
Deadline: Jun 30, 2025
Cardiovascular aging
BMC Cardiovascular Disorders is calling for submissions to our Collection on Cardiovascular aging. Cardiovascular aging represents a complex interplay of physiological, cellular, and molecular changes that significantly impact the structure and function of the heart and vasculature. As individuals age, they become increasingly susceptible to various clinical complications affecting the cardiovascular system. Such complications include, angina, arrithymias, anemia, atherosclerosis, coronary heart disease, aortic stenosis, congestive heart failure, hypertension/orthostatic hypotension, transient ischemic attacks, stroke, blood clots, deep vein thrombosis, peripheral vascular disease, varicose veins and aneurysms.
With aging populations experiencing a growing burden of cardiovascular disease, there is an urgent need to elucidate the fundamental processes driving cardiovascular aging, identify novel therapeutic targets, and develop innovative strategies to promote healthy aging and mitigate age-related cardiovascular risk factors.
In support of SDG 3: Good Health & Wellbeing, this Collection seeks contributions that address a spectrum of topics, including but not limited to:
• Age-related changes in cardiac structure and function
• Vascular aging and arterial stiffness
• Aging and atherosclerosis
• Age-related cardiovascular diseases
• Biomarkers of cardiovascular aging
• Cellular senescence in age-related cardiovascular disease
• Oxidative stress, inflammation and the immune system in age-related cardiovascular dysfunction
• Epigenetic mechanisms underlying age-related cardiovascular dysfunction
• Interventions to promote healthy aging
Publishing Model: Open Access
Deadline: May 20, 2025
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in